Cargando…

Use of antimalarial drugs in the treatment of COVID-19: A window of opportunity?()

Detalles Bibliográficos
Autores principales:	Lasheras, Isabel, Santabárbara, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242950/ https://www.ncbi.nlm.nih.gov/pubmed/32835091 http://dx.doi.org/10.1016/j.medcle.2020.04.002

Ejemplares similares

Uso de antipalúdicos en el tratamiento del COVID-19: ¿una ventana de oportunidad?
por: Lasheras, Isabel, et al.
Publicado: (2020)

Estimating the window of selection of antimalarial drugs using field data
por: Winter, Katherine, et al.
Publicado: (2012)

Prevalence of depression during the COVID-19 outbreak: A meta-analysis of community-based studies
por: Bueno-Notivol, Juan, et al.
Publicado: (2021)

Prevalence of Depression among Healthcare Workers during the COVID-19 Outbreak: A Systematic Review and Meta-Analysis
por: Olaya, Beatriz, et al.
Publicado: (2021)

Repurposing antimalarials and other drugs for COVID-19
por: Schlagenhauf, Patricia, et al.
Publicado: (2020)

Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities
por: Whitty, Christopher JM, et al.
Publicado: (2008)

Will the antimalarial drug take over to combat COVID-19?
por: T.K, Sivabakya, et al.
Publicado: (2020)

Exploiting an early immunological window of opportunity in COVID-19
por: Russell, Clark D
Publicado: (2021)

Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications
por: Ong, Wei-Yi, et al.
Publicado: (2020)

Window of Opportunity
Publicado: (1996)

COVID-19: A Window of Opportunity for Positive Healthcare Reforms
por: Auener, Stefan, et al.
Publicado: (2020)

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery
por: Shibeshi, Melkamu Adigo, et al.
Publicado: (2020)

COVID-19 – A window of opportunity for the transition toward sustainable mobility?
por: Schmidt, Karolin, et al.
Publicado: (2021)

Prevalence of Anxiety in Medical Students during the COVID-19 Pandemic: A Rapid Systematic Review with Meta-Analysis
por: Lasheras, Isabel, et al.
Publicado: (2020)

Trends in Antimalarial Drug Use in Africa
por: Flegg, Jennifer A., et al.
Publicado: (2013)

Opening windows of opportunity for smoking cessation treatment
por: Castellano, Maria Vera Cruz de Oliveira
Publicado: (2018)

Prevalence of anxiety in the COVID-19 pandemic: An updated meta-analysis of community-based studies
por: Santabárbara, Javier, et al.
Publicado: (2021)

Clinical Trials for COVID‐19: Can we Better Use the Short Window of Opportunity?
por: Eichler, Hans‐Georg, et al.
Publicado: (2020)

Host-directed therapy, an untapped opportunity for antimalarial intervention
por: Wei, Ling, et al.
Publicado: (2021)

The impact of COVID-19 on the evolution of online retail: The pandemic as a window of opportunity
por: Szász, Levente, et al.
Publicado: (2022)

COVID-19 as a window of opportunity for cycling: Evidence from the first wave
por: Büchel, Beda, et al.
Publicado: (2022)

Response: How to Use a Window of Opportunity
por: Chisolm, Margaret S., et al.
Publicado: (2011)

In Response to: Corticosteroids in Non-severe COVID-19: Finding Window of Opportunity
por: Nasa, Prashant, et al.
Publicado: (2022)

Windows of opportunity for Ebola virus infection treatment and vaccination
por: Nguyen, Van Kinh, et al.
Publicado: (2017)

Potential Positive Effects of COVID-19 on Cancer Care: A Window of Opportunity
por: Damilakis, Emmanouil
Publicado: (2022)

Antimalarials as Antivirals for COVID-19: Believe it or Not!
por: Saha, Biplab K., et al.
Publicado: (2020)

Ethics and Antimalarial Drug Resistance
por: Cheah, Phaik Yeong, et al.
Publicado: (2020)

Herbicidal properties of antimalarial drugs
por: Corral, Maxime G., et al.
Publicado: (2017)

Erratum: Lasheras, I.; et al. Prevalence of Anxiety in Medical Students during the COVID-19 Pandemic: A Rapid Systematic Review with Meta-Analysis. Int. J. Environ. Res. Public Health 2020, 17, 6603
por: Lasheras, Isabel, et al.
Publicado: (2020)

Windows of opportunity for the peopling of the Americas
por: Lesnek, Alia J.
Publicado: (2023)

Antimalarial drug resistance: An overview
por: Antony, Hiasindh Ashmi, et al.
Publicado: (2016)

Growing Up in Times of COVID-19: When a Window of Opportunity is Temporarily Closed
por: Keijsers, Loes, et al.
Publicado: (2021)

The COVID-19 pandemic as a window of opportunity for more sustainable and circular supply chains
por: Alva Ferrari, Ariana, et al.
Publicado: (2023)

Antimalarial drugs—are they beneficial in rheumatic and viral diseases?—considerations in COVID-19 pandemic
por: Grygiel-Górniak, Bogna
Publicado: (2021)

The Use of Antimalarial Drugs against Viral Infection
por: D’Alessandro, Sarah, et al.
Publicado: (2020)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
por: Price, Ric N, et al.
Publicado: (2007)

Regulators split on antimalarials for COVID-19
por: Jaffe, Susan
Publicado: (2020)

Awareness of pandemics and the impact of COVID-19()
por: Buesa, Alejandro, et al.
Publicado: (2021)

Antimalarial drug and renal toxicity
por: Wiwanitkit, Viroj
Publicado: (2015)

The threat of antimalarial drug resistance
por: Hanboonkunupakarn, Borimas, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pdqdk4mb9pd3cgjktelstffs4q